Rotow Reviews Key Updates on the Management of CNS Metastases in NSCLC
Season 11, Episode 1, Aug 08, 08:48 PM
Dr Rotow discusses data that demonstrated the central nervous system activity of datopotamab deruxtecan and osimertinib in patients with NSCLC.